$GERN Income Statement | Understand Stock

$GERN

$1.15 +$0.00 (0.0%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Product revenues, net
License Fees And Royalties Member
Royalties
Total revenues
Costs and operating expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Restructuring charges
Total costs and operating expenses
Loss from operations
Interest income
Interest expense
Other income (expense), net
Loss on extinguishment of debt
Net loss
Basic and diluted net loss per share
Shares used in computing basic and diluted net loss per share
Basic net loss per share (in dollars per share)
Diluted net loss per share (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments